Compounds > himachalene
Page last updated: 2024-11-12

himachalene

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

himachalene: structure in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

(R)-beta-himachalene : The (R)-enantiomer of beta-himachalene. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Cross-References

ID SourceID
PubMed CID11586487
CHEBI ID49208
MeSH IDM0368349

Synonyms (24)

Synonym
1h-benzocycloheptene, 2,4a.beta.,5,6,7,8-hexahydro-3,5,5,9-tetramethyl-, (+)-
1h-benzocycloheptene, 2,4a,5,6,7,8-hexahydro-3,5,5,9-tetramethyl-, (r)-
himachalene
(4ar)-3,5,5,9-tetramethyl-2,4a,5,6,7,8-hexahydro-1h-benzo[7]annulene
(r)-2,4a,5,6,7,8-hexahydro-3,5,5,9-tetramethyl-1h-benzocycloheptene
beta-himachalene
1461-03-6
(+)-2,4abeta,5,6,7,8-hexahydro-3,5,5,9-tetramethyl-1h-benzocycloheptene
CHEBI:49208
himachal-1(11),4-diene
(r)-beta-himachalene
unii-f8y2422o3m
1h-benzocycloheptene, 2,4abeta,5,6,7,8-hexahydro-3,5,5,9-tetramethyl-, (+)-
f8y2422o3m ,
LCOSCMLXPAQCLQ-AWEZNQCLSA-N
.beta.-himachalene
1h-benzocycloheptene, 2,4a,5,6,7,8-hexahydro-3,5,5,9-tetramethyl-, (4ar)-
3,5,5,9-tetramethyl-2,4a,5,6,7,8-hexahydro-1h-benzo[a]cycloheptene-, (r)-
(+)-.beta.-himachalene
1h-benzocycloheptene, 2,4a,5,6,7,8-hexahydro-3,5,5,9-tetramethyl-, (4ar)
.beta.-himachalene, (+)-
(4ar)-3,5,5,9-tetramethyl-1,2,4a,6,7,8-hexahydrobenzo[7]annulene
Q27121532
(r)-3,5,5,9-tetramethyl-2,4a,5,6,7,8-hexahydro-1h-benzo[7]annulene
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Drug Classes (1)

ClassDescription
beta-himachalene
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Research

Studies (12)

TimeframeStudies, This Drug (%)All Drugs %
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's3 (25.00)29.6817
2010's7 (58.33)24.3611
2020's2 (16.67)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 30.94

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index30.94 (24.57)
Research Supply Index2.56 (2.92)
Research Growth Index5.15 (4.65)
Search Engine Demand Index36.71 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (30.94)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other12 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]
SubstanceRelationship StrengthStudiesTrialsClassesRoles
alpha-pinene
[no description available]		2.1310pineneplant metabolite
vinyl bromide
vinyl bromide: structure		7.0710bromoalkene;
monohaloethene
3-chloroperbenzoic acid
3-chloroperbenzoic acid: oxidizing agent		210monochlorobenzenes;
peroxy acid
alpha-bergamotene
alpha-bergamotene: RR (13434-59-4) refers to the (trans)-isomer. alpha-bergamotene : A sesquiterpene consisting of a bicyclo[3.1.1]hept-2-ene skeleton substituted at positions 2 and 6 by methyl groups and at position 6 by a 4-methylpent-3-en-1-yl group.		2.0710bridged compound;
polycyclic olefin;
sesquiterpene		plant metabolite;
volatile oil component
himachalol
himachalol: structure		7.610himachalane sesquiterpenoid
ar-turmerone
ar-turmerone: potent antivenom against snake bites; isolated form Curcuma longa; structure given in first source. (+)-(S)-ar-turmerone : A sesquiterpenoid that is 2-methylhept-2-en-4-one substituted by a 4-methylphenyl group at position 6. It has been isolated from Peltophorum dasyrachis.		2.110enone;
sesquiterpenoid		EC 3.1.1.7 (acetylcholinesterase) inhibitor;
plant metabolite
alpha-asarone
asarone: structure in Merck Index, 9th ed, #847. asarone : A phenylpropanoid that is benzene substituted by methoxy groups at positions 1, 2 and 4 and a propen-1-yl group at position 5. It has been isolated from Acorus.. alpha-asarone : The trans-isomer of asarone.		2.1310asaroneanticonvulsant;
GABA modulator
sesquiterpenes
[no description available]		3.87110
1,1-diphenyl-2-picrylhydrazyl
1,1-diphenyl-2-picrylhydrazyl: A diphenyl picrate; the ability to decolorize this stable radical indicates reactivity of tested compounds (Banda, Anal Chem 46:1772-7 1974)		2.0710
humulene
humulene: structure given in first source. (1E,4E,8E)-alpha-humulene : The (1E,4E,8E)-isomer of alpha-humulene.		2.110alpha-humulene
caryophyllene
caryophyllene: RN given refers to cpd without isomeric designation; structure given in first source		2.110
germacrene d
germacrene D: RN in 9th CI Form Index for unspecified stereoisomer: 37839-63-7		2.110
cadinol
cadinol: from callus cultures of Chamomilla recutita (Asteraceae)		2.0710
cedrene
cedrene: major constituent of cedarwood oil. cedr-8-ene : A sesquiterpene that is cedrane which has a double bond between positions 8 and 9.		2.0710bridged compound;
carbotricyclic compound;
polycyclic olefin;
sesquiterpene		human urinary metabolite;
volatile oil component
ConditionIndicatedRelationship StrengthStudiesTrials
Black Fever
[description not available]		02.1510
Leishmaniasis, Visceral
A chronic disease caused by LEISHMANIA DONOVANI and transmitted by the bite of several sandflies of the genera Phlebotomus and Lutzomyia. It is commonly characterized by fever, chills, vomiting, anemia, hepatosplenomegaly, leukopenia, hypergammaglobulinemia, emaciation, and an earth-gray color of the skin. The disease is classified into three main types according to geographic distribution: Indian, Mediterranean (or infantile), and African.		02.1510